The pros and cons of discontinuing disease-modifying therapies in multiple sclerosis.
Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.
I love this Rx site. I can look up all the drugs I can't afford.
New guidelines reflect a growing interest in behavioral treatments and neuromodulation.
Many physicians want it, many patients are asking for it. Here’s a look at the pros and cons-and the case for expanded coverage of telemedicine.
Two young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?
Two young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?
Adherence is a major concern for clinicians across all disciplines. Even the most effective treatment will not be successful if the patients does not adhere to the prescribed treatment strategy. Inside learn more about the problem and ways to maximize adherence.
Researchers discussed external devices that would allow individuals to monitor clinical and subclinical seizure activity in their home environment
In case you missed the recent publication of these books, they are presented here for your library. Is there a recent book missing from this list you’d like to review, let us know!
This study showed that a novel CVS device provided effective, well-tolerated adjuvant prophylactic therapy for a group of adults with episodic migraine.
Can we see changes in the brain that correspond to cognitive difficulties? Research presented at AAN 2016 offers compelling information.
At the recent American Headache Society meeting, researchers detailed the manifold risks of opioid use in patients with migraine.
Inquiring about memory in older persons during routine clinical examination may identify persons who might be at higher risk for stroke.
Case 1 (of 4): Increasingly disruptive behavior and possible deteriorating cognitive function in a young girl with a previous right hemispherectomy.
Which came first? Epilepsy or depression? The author sheds light on a complex relationship.
There is no approved screening tool for misophonia, but a case review can lead to a diagnosis. Several treatment options may aid in symptom management.
Researchers investigated a possible quantitative measure of taste function that correlated with myelin-related lesions found in MS patients.
The 1-leg standing test is an easy way to determine if a patient has early signs of being at risk for a stroke and cognitive impairment and whether additional evaluation is needed,
Long-term consumption of fruits and vegetables may be associated with a lower risk of memory loss over time in men.
Our patients have a huge need for access to specialists, yet unfortunately, there is a huge shortage of headache specialists.
Neurologists will need to improve documentation for several common diagnoses to make a successful ICD-10 transition. Here are six helpful tips.
Two young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?
We are very pleased to welcome Heidi Moawad, MD as the first ever Editor in Chief of our journal, beginning February 1, 2019.
Drugs often involve multiple daily doses with complex dosing regimens, but interventions that have been applied generically to patients with chronic diseases can be applied to these cases as well.
The neurologist at Christus St. Vincent Health System detailed the areas of research dedicated to understanding more about neuropsychiatric symptoms of Parkinson disease and the root causes of the disease. [WATCH TIME: 3 minutes]
New findings may have an impact on reducing the epilepsy disease burden in future generations.
A look into the numerous education series upcoming in 2021 by the Tuberous Sclerosis Alliance